Dehydrated Human Amnion/Chorion Membrane to Treat Venous Leg Ulcers: A Cost-Effectiveness Analysis
Summary: This cost-effectiveness analysis compared dehydrated human amnion/chorion membrane (dHACM) with standard care for venous leg ulcers. The results showed faster closure rates, fewer recurrences, and lower overall treatment costs, confirming dHACM as a clinically and economically viable option.
Key Highlights:
- Improved healing speed and reduced recurrence with dHACM.
- Lowered total care costs and fewer clinical visits required.
- Validated long-term cost-effectiveness for chronic ulcers.
- Reinforces biologic use in venous leg ulcer management.
Keywords:
dHACM,
venous leg ulcer,
biologic therapy,
cost analysis